Spectrum Pharmaceuticals, Inc. (SPPI - Free Report) announced that the company has initiated the registrational phase III study of qapzola (apaziquone) …
SmarTrend identified an Uptrend for Spectrum Pharmac (NASDAQ:SPPI) on June 9th, 2017 at $6.46. In approximately 2 months, Spectrum Pharmac has returned 46.75% as of today's recent price of $9.48. In the past 52 weeks, shares of …
Analysts reviewing Spectrum Pharmaceuticals, Inc. have recently updated their recommended buy/sell ratings and price targets on the stock. Based on their most recently released notes to investors, 1 analyst has a rating of “buy”, 1 …
The value of the investment in Spectrum Pharmaceuticals, Inc. increased from $16,000 to $27,000 increasing 68.8% …
The company makes data analytics software. Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) was up 3.9% to $9.59 and a $762 million market cap. The company makes drugs for cancer and blood diseases. Biolase Inc. (NASDAQ: …
On August 4, 2017, Spectrum Pharmaceuticals, Inc. (the “Company”) entered into an at market ... time up to an …
As of 1:28 p.m. EDT, shares of Spectrum Pharmaceuticals (NASDAQ: SPPI), a biotech developing treatments for ... which could put the brakes on the stock's …
Investing.com - Spectrum Pharmaceuticals Inc's (NASDAQ:SPPI) shares were …